Pfizer (NYSE:PFE) recently received a CDC recommendation for wider use of its RSV vaccine, ABRYSVO, in adults aged 50-59 at ...

The Trump administration is considering eliminating dozens of programs at HHS amid a mass reorganization of the agency.

Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...

Complex Pandemic Accord negotiations have been underway since 2021, with 13 formal meetings and numerous informal sessions.

Conference organizers share some key insights from the Kellogg Business of Healthcare Conference that explored the ...

Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug ...

A review of 600 US patients treated for suspected sepsis found 31.5% most likely didn't have a bacterial infection, while ...

The U.S. Veterans Administration measures a substantial reduction in its carbon footprint associated with patient travel by ...

To improve access to care, the Veterans Health Administration Innovation Ecosystem and VHA Veterans Transportation Program ...

A key vaccine advisory committee is meeting for the first time under new U.S. Health Secretary Robert F. Kennedy Jr., a ...

We are delighted to welcome Dr. Nicacio to the Protara team,” said Jesse Shefferman, Chief Executive Officer of Protara Therapeutics. “As a proven leader with deep expertise spanning all stages of ...